Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity

Cancer Research
Akshata R UdyavarVito Quaranta


Small cell lung cancer (SCLC) is a devastating disease due to its propensity for early invasion and refractory relapse after initial treatment response. Although these aggressive traits have been associated with phenotypic heterogeneity, our understanding of this association remains incomplete. To fill this knowledge gap, we inferred a set of 33 transcription factors (TF) associated with gene signatures of the known neuroendocrine/epithelial (NE) and non-neuroendocrine/mesenchymal-like (ML) SCLC phenotypes. The topology of this SCLC TF network was derived from prior knowledge and was simulated using Boolean modeling. These simulations predicted that the network settles into attractors, or TF expression patterns, that correlate with NE or ML phenotypes, suggesting that TF network dynamics underlie the emergence of heterogeneous SCLC phenotypes. However, several cell lines and patient tumor specimens failed to correlate with either the NE or ML attractors. By flow cytometry, single cells within these cell lines simultaneously expressed surface markers of both NE and ML differentiation, confirming the existence of a "hybrid" phenotype. Upon exposure to standard-of-care cytotoxic drugs or epigenetic modifiers, NE and ML cell popula...Continue Reading


Jun 1, 1971·Journal of Theoretical Biology·Stuart Kauffman
Jan 10, 2003·Nucleic Acids Research·V MatysE Wingender
Feb 13, 2004·Bioinformatics·Laurent GautierRafael A Irizarry
Oct 23, 2004·Science·ENCODE Project Consortium
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Feb 28, 2007·Trends in Molecular Medicine·Christine L Hann, Charles M Rudin
Oct 16, 2007·Journal of Theoretical Biology·Kai Willadsen, Janet Wiles
Nov 19, 2008·Source Code for Biology and Medicine·István AlbertReka Albert
Dec 31, 2008·BMC Bioinformatics·Peter Langfelder, Steve Horvath
Jul 15, 2009·Seminars in Cell & Developmental Biology·Sui HuangStuart Kauffman
Dec 25, 2009·Nature·Maria Stella CarroAntonio Iavarone
Apr 30, 2010·Bioinformatics·Matthew D Wilkerson, D Neil Hayes
Jun 26, 2010·Current Protocols in Cytometry·Nikesh KotechaJonathan M Irish
Aug 6, 2011·BMC Bioinformatics·Jeremy A MillerSteve Horvath
Nov 22, 2011·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Sui Huang
Jan 11, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·William D Travis
Apr 20, 2012·Nature Reviews. Cancer·Andriy MarusykKornelia Polyak
Jan 11, 2013·BMC Genomics·Jérôme JourquinBing Zhang
Jan 10, 2013·British Journal of Cancer·R FisherC Swanton
Apr 17, 2013·BMC Bioinformatics·Edward Y ChenAvi Ma'ayan
Sep 21, 2013·Nature·Corbin E Meacham, Sean J Morrison
Nov 1, 2013·Science Translational Medicine·Clinical Lung Cancer Genome Project (CLCGP), Network Genomic Medicine (NGM)
Aug 30, 2014·PloS One·Anthony SzedlakCarlo Piermarocchi
Jul 15, 2015·Nature·Julie GeorgeRoman K Thomas
Aug 11, 2015·Frontiers in Oncology·Mohit Kumar JollyHerbert Levine
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M RudinGiuseppe Giaccone
Nov 26, 2015·NPJ Systems Biology and Applications·Steven Nathaniel SteinwayReka Albert


Jun 24, 2017·Current Oncology Reports·Jonathan M LehmanPierre P Massion
Nov 18, 2017·PLoS Computational Biology·Anthony SzedlakCarlo Piermarocchi
Jan 18, 2019·Physical Biology·Jorge Gómez Tejeda ZañudoReka Albert
Jan 8, 2018·Journal of Pharmacokinetics and Pharmacodynamics·Peter BloomingdaleDonald E Mager
Aug 16, 2019·Oncotarget·Jonathan M Lehman, Pierre P aMassion
Dec 21, 2017·Médecine sciences : M/S·Zuzana SaidakAntoine Galmiche
Mar 31, 2019·Nature Reviews. Cancer·Charles M RudinAdi F Gazdar
Sep 11, 2020·Physical Review Letters·Shubham TripathiHerbert Levine
Jul 24, 2018·Frontiers in Pharmacology·Marco A De BastianiFabio Klamt
Jun 9, 2018·BMC Systems Biology·Brian C RossJames C Costello
Feb 4, 2021·Journal of Clinical Medicine·Adithya ChedereMohit Kumar Jolly
Mar 3, 2020·Journal of Theoretical Biology·Anna KonstorumSuzy V Torti
Jun 1, 2018·Current Opinion in Systems Biology·Jorge G T ZañudoReka Albert

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.